Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
synthetic cannabinoid
|
| gptkbp:agonist_of |
gptkb:CB1_receptor
gptkb:CB2_receptor |
| gptkbp:CASNumber |
131543-23-2
|
| gptkbp:category |
gptkb:naphthoylindole
cannabinoid receptor agonist |
| gptkbp:chemicalFormula |
C27H27NO3
|
| gptkbp:developedBy |
gptkb:Sterling_Winthrop
|
| https://www.w3.org/2000/01/rdf-schema#label |
WIN 55,212-2
|
| gptkbp:IUPACName |
gptkb:(R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl](1-naphthyl)methanone
|
| gptkbp:legalStatus |
not approved for medical use
|
| gptkbp:molecularWeight |
413.51 g/mol
|
| gptkbp:PubChem_CID |
5311103
|
| gptkbp:relatedTo |
gptkb:HU-210
gptkb:JWH-018 gptkb:WIN_55,212-3 |
| gptkbp:UNII |
6G8X5X638V
|
| gptkbp:used_in |
scientific research
|
| gptkbp:bfsParent |
gptkb:CNR1
|
| gptkbp:bfsLayer |
7
|